Organigram (OGI) Stock Price, News & Analysis

Company Overview

Organigram Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

Key Stats

• Today's Range: C$1.35 to C$1.41
• 50-Day Range: C$1.29 to C$1.78
• 52-Week Range: C$1.20 to C$3.09
• Volume: 138,206 shs
• Average Volume: 200,914 shs
• Market Capitalization: C$196.05 million
• P/E Ratio: 2.26
• Dividend Yield: N/A
• Price Target: C$3.13
• Consensus Rating: Buy

Organigram Stock Analysis - MarketRank™

Organigram scored higher than 65% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Organigram has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Organigram has a consensus price target of C$3.13, representing about 129.8% upside from its current price of C$1.36.

Amount of Analyst Coverage

Organigram has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Organigram is 2.26, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Organigram is 2.26, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.69.

Price to Earnings Growth Ratio

Organigram has a PEG Ratio of 0.42. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Organigram has a P/B Ratio of 0.38. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for OGI.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Organigram does not currently pay a dividend.

Dividend Growth

Organigram does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

3 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Organigram insiders have not sold or bought any company stock.

Percentage Held by Insiders

31.32% of the stock of Organigram is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

3.45% of the stock of Organigram is held by institutions.

Company Calendar

• Last Earnings: 8/11/2026
• Today: 10/04/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: TSE:OGI
• CIK: N/A
• Web: www.organigram.ca
• Phone: 844-644-4726
• Fax: N/A
• Employees: 1,139
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Organigram: C$3.13
• High Price Target: C$3.25
• Low Price Target: C$3.00
• Potential Upside/Downside: +129.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): C$0.60
• Trailing P/E Ratio: 2.26
• Forward P/E Ratio: 8.33
• P/E Growth: 0.42
• Net Income: -C$57.23 million
• Net Margins: 28.02%
• Pretax Margin: N/A
• Return on Equity: 21.99%
• Return on Assets: -5.56%

Debt

• Debt-to-Equity Ratio: 6.48
• Current Ratio: 2.61
• Quick Ratio: 2.62

Sales & Book Value

• Annual Sales: C$309.18 million
• Price / Sales: 0.63
• Cash Flow: C$0.35 per share
• Price / Cash Flow: 3.85
• Book Value: C$3.59 per share
• Price / Book: 0.38

Miscellaneous

• Outstanding Shares: 144,153,000
• Free Float: N/A
• Market Cap: C$196.05 million
• Optionable: Not Optionable
• Beta: 1.78